Terms: = Head and neck cancer AND WRN, RECQL2, 7486, ENSG00000165392, Q14191, RECQ3 AND Treatment
5 results:
1. The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A meta-analysis.
Xue S; Song G; Zhu Y; Zhang N; Tan Y
Oral Oncol; 2022 Dec; 135():106231. PubMed ID: 36327674
[TBL] [Abstract] [Full Text] [Related]
2. Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral cancer Stem Cells.
Hembram KC; Dash SR; Das B; Sethy C; Chatterjee S; Bindhani BK; Kundu CN
Mol Pharm; 2020 Jul; 17(7):2463-2472. PubMed ID: 32407635
[TBL] [Abstract] [Full Text] [Related]
3. The Expression of Checkpoint and DNA Repair Genes in head and neck cancer as Possible Predictive Factors.
Rusz O; Pál M; Szilágyi É; Rovó L; Varga Z; Tomisa B; Fábián G; Kovács L; Nagy O; Mózes P; Reisz Z; Tiszlavicz L; Deák P; Kahán Z
Pathol Oncol Res; 2017 Apr; 23(2):253-264. PubMed ID: 27411922
[TBL] [Abstract] [Full Text] [Related]
4. [Hereditary thyroid carcinoma and its molecular diagnostics].
Dvořáková S; Václavíková E; Sýkorová V; Hálková T; Bendlová B
Cesk Patol; 2014 Apr; 50(2):81-6. PubMed ID: 24758503
[TBL] [Abstract] [Full Text] [Related]
5. RECQL1 and wrn proteins are potential therapeutic targets in head and neck squamous cell carcinoma.
Arai A; Chano T; Futami K; Furuichi Y; Ikebuchi K; Inui T; Tameno H; Ochi Y; Shimada T; Hisa Y; Okabe H
Cancer Res; 2011 Jul; 71(13):4598-607. PubMed ID: 21571861
[TBL] [Abstract] [Full Text] [Related]
